TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33881209 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 33881463 — Surrogate Endpoint (SUR): Platelet count response
Study 33882028 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33882028 — Surrogate Endpoint (SUR): Blood pressure
Study 33882028 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 33882028 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33882143 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33882374 — Safety Biomarker (SAF): CREM mRNA
Genes: CREM
Study 33882846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33882862 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 33883176 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33883194 — Surrogate Endpoint (SUR): Blood pressure
Study 33883548 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33886085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33886789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33888899 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 33888899 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33890856 — Surrogate Endpoint (SUR): Blood pressure
Study 33892094 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33892111 — Surrogate Endpoint (SUR): Blood pressure
Study 33892407 — Safety Biomarker (SAF): Derived neutrophil to lymphocyte
Study 33892407 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33893160 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33893289 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33893289 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33893289 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 33893973 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study 33893973 — Safety Biomarker (SAF): N-acetylneuraminic acid
Study 33894474 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33894633 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33895322 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 33895695 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33895695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33895695 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33895695 — Predictive Biomarker (PRD): Hormone receptor
Study 33895809 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 33895809 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 33895809 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 33895809 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 33895809 — Predictive Biomarker (PRD): TCF3 mRNA
Genes: TCF3; BHLHB21; E2A; ITF1
Study 33895809 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 33895809 — Predictive Biomarker (PRD): PAX5 mRNA
Genes: PAX5
Study 33895809 — Predictive Biomarker (PRD): AFF1 mRNA
Genes: AFF1; AF4; FEL; MLLT2; PBM1
Study 33895809 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 33895809 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 33895809 — Predictive Biomarker (PRD): MEF2D mRNA
Genes: MEF2D
Study 33897480 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33898959 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 33898959 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 33900485 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33900485 — Predictive Biomarker (PRD): NR1D1 mRNA
Genes: NR1D1; EAR1; HREV; THRAL
Study 33900485 — Predictive Biomarker (PRD): NR1D2 mRNA
Genes: NR1D2
Study 33900485 — Predictive Biomarker (PRD): CRY1 mRNA
Genes: CRY1; PHLL1
Study 33900485 — Predictive Biomarker (PRD): PER2 mRNA
Genes: PER2; KIAA0347
Study 33901188 — Predictive Biomarker (PRD): ACTG1 mRNA
Genes: ACTG1; ACTG
Study 33901188 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 33901188 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33901551 — Surrogate Endpoint (SUR): Blood pressure
Study 33902556 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 33904646 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33904895 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33904996 — Surrogate Endpoint (SUR): Blood pressure
Study 33906377 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33906377 — Surrogate Endpoint (SUR): Serum sodium
Study 33906377 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 33909934 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33909934 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33909934 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 33909934 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33909934 — Predictive Biomarker (PRD): Hormone receptor
Study 33910089 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 33910277 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33912178 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33912178 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study 33912461 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 33912799 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33912999 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 33913006 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 33914096 — Surrogate Endpoint (SUR): Bone mineral density
Study 33914097 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 33914350 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33914706 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33917201 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 33920489 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33922391 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 33924960 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33927105 — Surrogate Endpoint (SUR): Blood pressure
Study 33927108 — Predictive Biomarker (PRD): Microsatellite instability
Study 33927586 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 33928466 — Predictive Biomarker (PRD): YTHDF1 mRNA
Genes: YTHDF1; C20orf21
Study 33929089 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33929327 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 33929327 — Predictive Biomarker (PRD): RRM2 mRNA
Genes: RRM2; RR2
Study 33929496 — Surrogate Endpoint (SUR): Blood pressure
Study 33931404 — Predictive Biomarker (PRD): SAA1 mRNA
Genes: SAA1
Study 33931404 — Predictive Biomarker (PRD): PAPPA mRNA
Genes: PAPPA
Study 33931953 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study 33931953 — Surrogate Endpoint (SUR): Serum uric acid
Study 33931953 — Surrogate Endpoint (SUR): Serum creatinine
Study 33932113 — Predictive Biomarker (PRD): FUT3 mRNA
Genes: FUT3; FT3B; LE
Study 33932130 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study 33932130 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 33932502 — Predictive Biomarker (PRD): Microsatellite instability
Study 33933118 — Predictive Biomarker (PRD): DARS1 mRNA
Genes: DARS1; DARS; PIG40
Study 33933408 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 33934706 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study 33935966 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 33936110 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33936110 — Safety Biomarker (SAF): Interleukin 1
Study 33937624 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33937953 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33937954 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33937954 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 33939067 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 33939068 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33939068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33939529 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33939604 — Predictive Biomarker (PRD): IVL mRNA
Genes: IVL
Study 33940642 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 33941281 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33941784 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study 33941784 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33941784 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 33941878 — Predictive Biomarker (PRD): AXIN2 mRNA
Genes: AXIN2
Study 33942031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33942298 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 33942954 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33944977 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 33944977 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 33945049 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33945296 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33945605 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 33946038 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33947359 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 33947471 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 33947698 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study 33947745 — Predictive Biomarker (PRD): MDC1 mRNA
Genes: MDC1; KIAA0170; NFBD1
Study 33947745 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33947785 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33947785 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 33949966 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33950298 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 33951076 — Predictive Biomarker (PRD): IVNS1ABP mRNA
Genes: IVNS1ABP; ARA3; FLARA3; KIAA0850; KLHL39; NS1; NS1BP; HSPC068
Study 33951732 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study 33951732 — Predictive Biomarker (PRD): CSF3R mRNA
Genes: CSF3R; GCSFR
Study 33951732 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study 33951890 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33951923 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 33952255 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33954826 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 33955129 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 33955129 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 33955376 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 33955376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33955376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33956057 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33956057 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33957168 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 33958126 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33959195 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33959195 — Surrogate Endpoint (SUR): Pathological complete response
Study 33959689 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 33960144 — Surrogate Endpoint (SUR): Blood pressure
Study 33960681 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 33961019 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 33961019 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 33961795 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33962566 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33962603 — Safety Biomarker (SAF): Reactive oxygen species
Study 33963014 — Surrogate Endpoint (SUR): Pathological complete response
Study 33963573 — Predictive Biomarker (PRD): MT2A mRNA
Genes: MT2A; CES1; MT2
Study 33963573 — Surrogate Endpoint (SUR): Blood pressure
Study 33963686 — Surrogate Endpoint (SUR): Bone mineral density
Study 33964451 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33964451 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33964451 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 33964942 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study 33965000 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 33965236 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study 33965236 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33965236 — Surrogate Endpoint (SUR): Serum creatinine
Study 33965384 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 33966020 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33966452 — Surrogate Endpoint (SUR): Blood pressure
Study 33966635 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 33966635 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 33966635 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 33968064 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33968735 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 33969423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33970392 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33970454 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33970864 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 33971168 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 33971168 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33971168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33971856 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33972083 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33972949 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33972949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33972949 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33973232 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33973232 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 33973550 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study 33973868 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 33973868 — Surrogate Endpoint (SUR): Blood pressure
Study 33974038 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33974038 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33974366 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33974366 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33974569 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33974569 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 33974569 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 33975557 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33976135 — Safety Biomarker (SAF): Reactive oxygen species
Study 33976538 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33977686 — Safety Biomarker (SAF): miR-1
Study 33977686 — Predictive Biomarker (PRD): miR-19b-1
Genes: MIR19B1
Study 33977686 — Monitoring Biomarker (MOI): miR-181b-5p
Study 33977686 — Safety Biomarker (SAF): miR-423
Genes: MIR423
Study 33978191 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study 33978191 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 33978593 — Surrogate Endpoint (SUR): Blood pressure
Study 33978600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33978600 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33979100 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33979178 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 33979178 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 33979178 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33979314 — Safety Biomarker (SAF): miR-22
Genes: MIR22
Study 33979314 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 33979314 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 33979314 — Safety Biomarker (SAF): miR-192
Genes: MIR192
Study 33979314 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-210
Genes: MIR210
Study 33980287 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study 33980522 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 33980575 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33981160 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33981389 — Surrogate Endpoint (SUR): Probing pocket depth
Study 33981732 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 33981943 — Safety Biomarker (SAF): Lactotransferrin
Genes: LTF; GIG12; LF
Study 33982083 — Predictive Biomarker (PRD): ACTG1 mRNA
Genes: ACTG1; ACTG
Study 33982118 — Predictive Biomarker (PRD): ERFE mRNA
Genes: ERFE; C1QTNF15; CTRP15; FAM132B
Study 33982592 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33983131 — Surrogate Endpoint (SUR): Blood pressure
Study 33983492 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33983492 — Surrogate Endpoint (SUR): Pathological complete response
Study 33983671 — Predictive Biomarker (PRD): ACKR1 mRNA
Genes: ACKR1; DARC; FY; GPD
Study 33984672 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33984674 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33986057 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33986123 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 33986124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33986214 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33987718 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33988272 — Predictive Biomarker (PRD): ADA2 mRNA
Genes: ADA2; ADGF; CECR1; IDGFL
Study 33988272 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33988272 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33988513 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 33988513 — Surrogate Endpoint (SUR): Blood pressure
Study 33988517 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33989558 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33990084 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study 33990101 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study 33990496 — Surrogate Endpoint (SUR): Bone mineral density
Study 33990507 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 33990512 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33990512 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33990512 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33990649 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33991323 — Surrogate Endpoint (SUR): Blood pressure
Study 33992564 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33992635 — Predictive Biomarker (PRD): Microsatellite instability
Study 33993383 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 33994151 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 33994338 — Surrogate Endpoint (SUR): Blood pressure
Study 33995588 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33995588 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33995600 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33995600 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33995597 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33995988 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 33996511 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT